For N-acetyl-β-d-glucosaminidase and cathepsin B activity, multi comparison analysis indicated no differences in control and in the three classes of the Compliant GDM mother neonate subgroup (Figure 3). This evidence concerns the gene CTSB and gestational diabetes.